Effectiveness of a pleuroperitoneal shunt for refractory hepatic hydrothorax that appeared after ligation of a communicating hydrocele.
作者信息
Nakatsuji Yoshiyuki, Yoshizawa Mitsutaka, Ohyama Shigekazu
机构信息
Department of Gastroenterology, Marunouchi Hospital, Matsumoto, Nagano, Japan
Department of Clinical Engineering, Marunouchi Hospital, Matsumoto, Nagano, Japan.
出版信息
BMJ Case Rep. 2021 May 10;14(5):e242681. doi: 10.1136/bcr-2021-242681.
Abstract
摘要
相似文献
1
Effectiveness of a pleuroperitoneal shunt for refractory hepatic hydrothorax that appeared after ligation of a communicating hydrocele.交通性鞘膜积液结扎术后出现的顽固性肝性胸水行胸腹分流术的疗效
BMJ Case Rep. 2021 May 10;14(5):e242681. doi: 10.1136/bcr-2021-242681.
2
Transjugular intrahepatic portosystemic shunt in refractory hydrothorax - a contribution to an unexplored indication.经颈静脉肝内门体分流术治疗难治性胸腔积液——对一个未被探索适应症的贡献
Eur J Gastroenterol Hepatol. 2016 Jun;28(6):661-6. doi: 10.1097/MEG.0000000000000623.
3
Transjugular intrahepatic portosystemic shunt for the management of hepatic hydrothorax in the absence of ascites.经颈静脉肝内门体分流术用于治疗无腹水的肝性胸水
J Clin Gastroenterol. 1996 Jun;22(4):305-7. doi: 10.1097/00004836-199606000-00013.
4
Refractory hepatic hydrothorax treated with transjugular intrahepatic portosystemic shunt.经颈静脉肝内门体分流术治疗难治性肝性胸腔积液
J Gastroenterol. 1999 Feb;34(1):128-31. doi: 10.1007/s005350050228.
5
[Hydrothorax in absence of ascites: an unusual complication of hepatic cirrhosis with portal hypertension].[无腹水的胸腔积液：肝硬化门静脉高压的一种罕见并发症]
Clin Ter. 2005 Jul-Aug;156(4):179-81.
6
Further experiments are necessary to determine whether transjugular intrahepatic portosystemic shunt is the definitive treatment for refractory hepatic hydrothorax.有必要进行进一步的实验，以确定经颈静脉肝内门体分流术是否为难治性肝性胸腔积液的决定性治疗方法。
J Gastroenterol. 1999 Feb;34(1):154-6. doi: 10.1007/s005350050236.
7
[Treatment by porto-systemic intrahepatic shunt for refractory hydrothorax during cirrhosis].经颈静脉肝内门体分流术治疗肝硬化难治性胸腔积液
Gastroenterol Clin Biol. 1999 Mar;23(3):414-5.
8
Transjugular intrahepatic portosystemic shunts and liver transplantation in patients with refractory hepatic hydrothorax.经颈静脉肝内门体分流术与难治性肝性胸腔积液患者的肝移植
Liver Transpl Surg. 1998 Sep;4(5):416-23. doi: 10.1002/lt.500040506.
9
TIPS for patients with refractory hepatic hydrothorax: what is the take-home message?
Am J Gastroenterol. 1997 Nov;92(11):2129-30.
10
Parallel TIPS for treatment of refractory ascites and hepatic hydrothorax.用于治疗顽固性腹水和肝性胸水的并行经颈静脉肝内门体分流术
Dig Dis Sci. 2013 Oct;58(10):3052-6. doi: 10.1007/s10620-013-2688-8. Epub 2013 Apr 27.
引用本文的文献
1
Embryological, anatomical and clinical considerations on pleuroperitoneal communication.关于胸膜腹膜交通的胚胎学、解剖学及临床考量
Pleura Peritoneum. 2023 Jun 19;8(3):101-111. doi: 10.1515/pp-2023-0013. eCollection 2023 Sep.
本文引用的文献
1
Hepatorenal syndrome: pathophysiology, diagnosis, and management.肝肾综合征：病理生理学、诊断与治疗。
BMJ. 2020 Sep 14;370:m2687. doi: 10.1136/bmj.m2687.
2
Improvement of Major Problems in the Cell-Free and Concentrated Ascites Reinfusion Therapy System─Constructing of Cell-Free and Concentrated Ascites Reinfusion Therapy System Using External Pressure for Filtration.无细胞浓缩腹水回输治疗系统主要问题的改进─利用外压过滤构建无细胞浓缩腹水回输治疗系统
Ther Apher Dial. 2019 Jun;23(3):233-236. doi: 10.1111/1744-9987.12829.
3
Usefulness of a pleuroperitoneal shunt for treatment of refractory pleural effusion in a patient receiving maintenance hemodialysis.在接受维持性血液透析的患者中，胸膜腹膜分流术治疗难治性胸腔积液的效用。
CEN Case Rep. 2018 Nov;7(2):189-194. doi: 10.1007/s13730-018-0323-4. Epub 2018 Mar 23.
4
Evidence-based incorporation of serum sodium concentration into MELD.将血清钠浓度基于证据纳入终末期肝病模型（MELD）
Gastroenterology. 2006 May;130(6):1652-60. doi: 10.1053/j.gastro.2006.02.010.
5
Hepatic hydrothorax: pathogenesis, diagnosis, and management.肝性胸水：发病机制、诊断与管理
Am J Med. 1999 Sep;107(3):262-7. doi: 10.1016/s0002-9343(99)00217-x.
Zotero 插件